PharmaCyte Biotech, Inc's board of directors have approved an amendment to the company's bylaws, allowing for the board to fix a record date for an adjourned or postponed meeting. Additionally, the company's special meeting of shareholders has been rescheduled to August 31, 2023 to consider a new proposal.